| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |